Proteoliposomal formulations of an HIV-1 gp41-based miniprotein elicit a lipid-dependent immunodominant response overlapping the 2F5 binding motif
暂无分享,去创建一个
Jordi Villà-Freixa | Jorge Carrillo | Cristina Vilaplana | J. A. Nieto-Garai | Bonaventura Clotet | Nuria Izquierdo-Useros | Martin Floor | Luis Agulló | B. Clotet | J. Martinez-Picado | S. Marfil | L. Agulló | J. Blanco | Luis M Molinos-Albert | J. Carrillo | Maier Lorizate | F. Contreras | P. Cardona | Maier Lorizate | C. Vilaplana | Javier Martinez-Picado | J. Villà-Freixa | Julià Blanco | Luis M. Molinos-Albert | Eneritz Bilbao | Silvia Marfil | Elisabet García | Maria Luisa Rodríguez de la Concepción | Jon A. Nieto-Garai | F.-Xabier Contreras | Pere J. Cardona | Martin Floor | N. Izquierdo-Useros | Elisabet García | Eneritz Bilbao | L. M. Molinos-Albert | M. Concepcion | Jordi Villà-Freixa
[1] B. Haynes,et al. HIV‐1 neutralizing antibodies: understanding nature's pathways , 2013, Immunological reviews.
[2] Chaim A. Schramm,et al. Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus , 2013, Nature.
[3] S. Nir,et al. Sphingomyelin and Cholesterol Promote HIV-1 gp41 Pretransmembrane Sequence Surface Aggregation and Membrane Restructuring* , 2002, The Journal of Biological Chemistry.
[4] D R Burton,et al. Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. , 1994, Science.
[5] R. Blumenthal,et al. Role of the Membrane-Proximal Domain in the Initial Stages of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein-Mediated Membrane Fusion , 1999, Journal of Virology.
[6] V. Brusic,et al. HIV-1 broadly neutralizing antibody extracts its epitope from a kinked gp41 ectodomain region on the viral membrane. , 2008, Immunity.
[7] R. Coffman,et al. Vaccine adjuvants: putting innate immunity to work. , 2010, Immunity.
[8] L. Mayer,et al. Vesicles of variable sizes produced by a rapid extrusion procedure. , 1986, Biochimica et biophysica acta.
[9] J. Kappes,et al. Neutralizing antibodies induced by liposomal HIV-1 glycoprotein 41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes , 2009, AIDS.
[10] M. Carrington,et al. HIV-1 Antibody Neutralization Breadth Is Associated with Enhanced HIV-Specific CD4+ T Cell Responses , 2015, Journal of Virology.
[11] C. Genin,et al. Identification of a conserved domain of the HIV-1 transmembrane protein gp41 which interacts with cholesteryl groups. , 2002, Biochimica et biophysica acta.
[12] James D. Scott,et al. Response to Comments on “Slow adaptation in the face of rapid warming leads to collapse of the Gulf of Maine cod fishery” , 2016, Science.
[13] Hanqin Peng,et al. Mechanism of HIV-1 Neutralization by Antibodies Targeting a Membrane-Proximal Region of gp41 , 2013, Journal of Virology.
[14] M. Khan,et al. Targeting to macrophages: role of physicochemical properties of particulate carriers--liposomes and microspheres--on the phagocytosis by macrophages. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[15] D. Montefiori,et al. A Fusion Intermediate gp41 Immunogen Elicits Neutralizing Antibodies to HIV-1* , 2014, The Journal of Biological Chemistry.
[16] Hans-Georg Kräusslich,et al. Role of lipids in virus replication. , 2011, Cold Spring Harbor perspectives in biology.
[17] D. Andreu,et al. Membrane-transferring sequences of the HIV-1 Gp41 ectodomain assemble into an immunogenic complex. , 2006, Journal of molecular biology.
[18] A. Herrmann,et al. αEnv-decorated phosphatidylserine liposomes trigger phagocytosis of HIV-virus-like particles in macrophages. , 2014, Nanomedicine : nanotechnology, biology, and medicine.
[19] Michael A. Johnston,et al. The role of residue stability in transient protein–protein interactions involved in enzymatic phosphate hydrolysis. A computational study , 2005, Proteins.
[20] S. Sligar,et al. Trimerization of the HIV Transmembrane Domain in Lipid Bilayers Modulates Broadly Neutralizing Antibody Binding. , 2016, Angewandte Chemie.
[21] C. Soto,et al. Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody , 2016, Science.
[22] T. Kepler,et al. Two Distinct Broadly Neutralizing Antibody Specificities of Different Clonal Lineages in a Single HIV-1-Infected Donor: Implications for Vaccine Design , 2012, Journal of Virology.
[23] Pham Phung,et al. Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target , 2009, Science.
[24] Wayne C Koff,et al. Broadly neutralizing HIV antibodies define a glycan-dependent epitope on the prefusion conformation of gp41 on cleaved envelope trimers. , 2014, Immunity.
[25] Differentiation between transmembrane helices and peripheral helices by the deconvolution of circular dichroism spectra of membrane proteins , 1992, Protein science : a publication of the Protein Society.
[26] R. Hodges,et al. Designing heterodimeric two-stranded alpha-helical coiled-coils. Effects of hydrophobicity and alpha-helical propensity on protein folding, stability, and specificity. , 2002, The Journal of biological chemistry.
[27] A. Waring,et al. Membrane-perturbing domains of HIV type 1 glycoprotein 41. , 2001, AIDS research and human retroviruses.
[28] James C. Paulson,et al. Antigen Delivery to Macrophages Using Liposomal Nanoparticles Targeting Sialoadhesin/CD169 , 2012, PloS one.
[29] Dennis R. Burton,et al. A Limited Number of Antibody Specificities Mediate Broad and Potent Serum Neutralization in Selected HIV-1 Infected Individuals , 2010, PLoS pathogens.
[30] Gwo-Yu Chuang,et al. Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-120 interface , 2014, Nature.
[31] I. Wilson,et al. Insights into the trimeric HIV-1 envelope glycoprotein structure. , 2015, Trends in biochemical sciences.
[32] H. Liao,et al. Induction of Antibodies in Rhesus Macaques That Recognize a Fusion-Intermediate Conformation of HIV-1 gp41 , 2011, PloS one.
[33] G. Winberg,et al. Signal sequence deletion and fusion to tetanus toxoid epitope augment antitumor immune responses to a human carcinoembryonic antigen (CEA) plasmid DNA vaccine in a murine test system , 2003, Cancer Gene Therapy.
[34] D. Irvine,et al. Immunogenicity of Membrane-bound HIV-1 gp41 Membrane-proximal External Region (MPER) Segments Is Dominated by Residue Accessibility and Modulated by Stereochemistry* , 2013, The Journal of Biological Chemistry.
[35] S. Segawa,et al. End of the beginning , 1990, Nature.
[36] Martin F. Bachmann,et al. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns , 2010, Nature Reviews Immunology.
[37] P. Williamson,et al. Exposure of phosphatidylserine is a general feature in the phagocytosis of apoptotic lymphocytes by macrophages , 1999, Cell Death and Differentiation.
[38] Leaf Huang,et al. Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens. , 2012, Vaccine.
[39] A. Telenti,et al. Siglec-1 Is a Novel Dendritic Cell Receptor That Mediates HIV-1 Trans-Infection Through Recognition of Viral Membrane Gangliosides , 2012, PLoS biology.
[40] Renate Kunert,et al. Comprehensive Cross-Clade Neutralization Analysis of a Panel of Anti-Human Immunodeficiency Virus Type 1 Monoclonal Antibodies , 2004, Journal of Virology.
[41] Ben Murrell,et al. Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection Cohort , 2016, PLoS pathogens.
[42] D. Leaman,et al. Targeting HIV-1 gp41 in close proximity to the membrane using antibody and other molecules. , 2011, Current topics in medicinal chemistry.
[43] J. Hoxie,et al. Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor , 2014, Science Translational Medicine.
[44] Baoshan Zhang,et al. Broad and potent neutralization of HIV-1 by a gp41-specific human antibody , 2012, Nature.
[45] M. Bomsel,et al. HIV-1 gp41 Envelope Residues 650–685 Exposed on Native Virus Act as a Lectin to Bind Epithelial Cell Galactosyl Ceramide* , 2002, The Journal of Biological Chemistry.
[46] J. Mascola,et al. Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning , 2013, Nature Reviews Immunology.
[47] K Schulten,et al. VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.
[48] Laxmikant V. Kalé,et al. Scalable molecular dynamics with NAMD , 2005, J. Comput. Chem..
[49] Paul W. H. I. Parren,et al. Broadly Neutralizing Antibodies Targeted to the Membrane-Proximal External Region of Human Immunodeficiency Virus Type 1 Glycoprotein gp41 , 2001, Journal of Virology.
[50] Cédric Notredame,et al. 3DCoffee: combining protein sequences and structures within multiple sequence alignments. , 2004, Journal of molecular biology.
[51] B. Clotet,et al. A cell-to-cell HIV transfer assay identifies humoral responses with broad neutralization activity. , 2011, Vaccine.
[52] Terri Wrin,et al. Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm , 2009, Journal of Virology.
[53] K. Tsumoto,et al. The Atomic Structure of the HIV-1 gp41 Transmembrane Domain and Its Connection to the Immunogenic Membrane-proximal External Region*♦ , 2015, The Journal of Biological Chemistry.
[54] J. Mascola,et al. Relationship between Antibody 2F5 Neutralization of HIV-1 and Hydrophobicity of Its Heavy Chain Third Complementarity-Determining Region , 2009, Journal of Virology.
[55] J. Mascola,et al. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies , 2000, Nature Medicine.
[56] B. Haynes,et al. Modulation of Nonneutralizing HIV-1 gp41 Responses by an MHC-Restricted TH Epitope Overlapping Those of Membrane Proximal External Region Broadly Neutralizing Antibodies , 2014, The Journal of Immunology.
[57] T. Blundell,et al. Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.
[58] D. Burton,et al. Aromatic residues at the edge of the antibody combining site facilitate viral glycoprotein recognition through membrane interactions , 2010, Proceedings of the National Academy of Sciences.
[59] Darrell J Irvine,et al. Liposomal vaccines incorporating molecular adjuvants and intrastructural T-cell help promote the immunogenicity of HIV membrane-proximal external region peptides. , 2015, Vaccine.
[60] Han Gao,et al. Antibody 8ANC195 reveals a site of broad vulnerability on the HIV-1 envelope spike. , 2014, Cell reports.
[61] P. Earl,et al. Epitope map of human immunodeficiency virus type 1 gp41 derived from 47 monoclonal antibodies produced by immunization with oligomeric envelope protein , 1997, Journal of virology.
[62] Lynn Morris,et al. Profiling the Specificity of Neutralizing Antibodies in a Large Panel of Plasmas from Patients Chronically Infected with Human Immunodeficiency Virus Type 1 Subtypes B and C , 2008, Journal of Virology.
[63] Hans-Georg Kräusslich,et al. The HIV lipidome: a raft with an unusual composition. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[64] Yifan Cheng,et al. A fusion-intermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodies , 2008, Proceedings of the National Academy of Sciences.
[65] E. Hunter,et al. A Conserved Tryptophan-Rich Motif in the Membrane-Proximal Region of the Human Immunodeficiency Virus Type 1 gp41 Ectodomain Is Important for Env-Mediated Fusion and Virus Infectivity , 1999, Journal of Virology.
[66] Mario Roederer,et al. Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1 , 2010, Science.
[67] Hans-Georg Kräusslich,et al. Comparative lipidomics analysis of HIV‐1 particles and their producer cell membrane in different cell lines , 2013, Cellular microbiology.
[68] I. Wilson,et al. Crystallographic Identification of Lipid as an Integral Component of the Epitope of HIV Broadly Neutralizing Antibody 4E10. , 2016, Immunity.
[69] G Himmler,et al. A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1 , 1993, Journal of virology.
[70] J. Martinez-Picado,et al. Sialyllactose in Viral Membrane Gangliosides Is a Novel Molecular Recognition Pattern for Mature Dendritic Cell Capture of HIV-1 , 2012, PLoS biology.
[71] B. Clotet,et al. Anti-MPER antibodies with heterogeneous neutralization capacity are detectable in most untreated HIV-1 infected individuals , 2014, Retrovirology.
[72] D. Trono,et al. Role for Human Immunodeficiency Virus Type 1 Membrane Cholesterol in Viral Internalization , 2002, Journal of Virology.
[73] Sunhwan Jo,et al. CHARMM‐GUI Membrane Builder toward realistic biological membrane simulations , 2014, J. Comput. Chem..
[74] P. S. Kim,et al. Side-chain repacking calculations for predicting structures and stabilities of heterodimeric coiled coils , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[75] Pham Phung,et al. Broad neutralization coverage of HIV by multiple highly potent antibodies , 2011, Nature.
[76] W. Weissenhorn,et al. A gp41 MPER-specific Llama VHH Requires a Hydrophobic CDR3 for Neutralization but not for Antigen Recognition , 2013, PLoS pathogens.
[77] H. Katinger,et al. The Long Third Complementarity-Determining Region of the Heavy Chain Is Important in the Activity of the Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2F5 , 2004, Journal of Virology.
[78] R. Hodges,et al. Designing Heterodimeric Two-stranded α-Helical Coiled-coils , 2002, The Journal of Biological Chemistry.
[79] H. Liao,et al. Role of HIV membrane in neutralization by two broadly neutralizing antibodies , 2009, Proceedings of the National Academy of Sciences.
[80] F. Batista,et al. B cells acquire particulate antigen in a macrophage-rich area at the boundary between the follicle and the subcapsular sinus of the lymph node. , 2007, Immunity.
[81] D. Burton,et al. Broadly Neutralizing Monoclonal Antibodies 2F5 and 4E10 Directed against the Human Immunodeficiency Virus Type 1 gp41 Membrane-Proximal External Region Protect against Mucosal Challenge by Simian-Human Immunodeficiency Virus SHIVBa-L , 2009, Journal of Virology.
[82] H. Katinger,et al. Anti-Human Immunodeficiency Virus Type 1 (HIV-1) Antibodies 2F5 and 4E10 Require Surprisingly Few Crucial Residues in the Membrane-Proximal External Region of Glycoprotein gp41 To Neutralize HIV-1 , 2005, Journal of Virology.
[83] Pojen P. Chen,et al. The Role of Antibody Polyspecificity and Lipid Reactivity in Binding of Broadly Neutralizing Anti-HIV-1 Envelope Human Monoclonal Antibodies 2F5 and 4E10 to Glycoprotein 41 Membrane Proximal Envelope Epitopes1 , 2007, The Journal of Immunology.
[84] F. Wieland,et al. Probing HIV-1 Membrane Liquid Order by Laurdan Staining Reveals Producer Cell-dependent Differences* , 2009, The Journal of Biological Chemistry.
[85] J. L. Nieva,et al. Lipid modulation of membrane‐bound epitope recognition and blocking by HIV‐1 neutralizing antibodies , 2008, FEBS letters.
[86] Jamie K. Scott,et al. The Membrane-Proximal External Region of the Human Immunodeficiency Virus Type 1 Envelope: Dominant Site of Antibody Neutralization and Target for Vaccine Design , 2008, Microbiology and Molecular Biology Reviews.
[87] Long Wang,et al. Win-Stay-Lose-Learn Promotes Cooperation in the Spatial Prisoner's Dilemma Game , 2012, PloS one.
[88] B. Reinhard,et al. Lipid-Mediated Targeting with Membrane-Wrapped Nanoparticles in the Presence of Corona Formation. , 2016, ACS nano.